MedPath
NMPA Approval

Gefitinib Tablets

国药准字H20243617

April 24, 2024

Drug Information

吉非替尼片

片剂

0.25g

化学药品

April 24, 2024

Company Information

Applicant Company

山东费县北外环路1号

Manufacturing Company

山东费县北外环路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吉非替尼片 - NMPA 批准文号 | MedPath